BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28714006)

  • 21. Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes.
    Vivekanandan P; Torbenson M; Ramakrishna B
    J Gastrointest Cancer; 2011 Mar; 42(1):20-5. PubMed ID: 20963515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.
    Chen JD; Liu CJ; Lee PH; Chen PJ; Lai MY; Kao JH; Chen DS
    Clin Gastroenterol Hepatol; 2004 Jan; 2(1):64-71. PubMed ID: 15017634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
    Chen XQ; He JR; Wang HY
    Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
    Zhang QX; Yao YQ; Li SL; Long Q
    Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-Wide Association Study of MKI67 Expression and its Clinical Implications in HBV-Related Hepatocellular Carcinoma in Southern China.
    Yang CK; Yu TD; Han CY; Qin W; Liao XW; Yu L; Liu XG; Zhu GZ; Su H; Lu SC; Chen ZW; Liu Z; Huang KT; Liu ZT; Liang Y; Huang JL; Mo ZN; Qin X; Li L; Xiao KY; Peng MH; Winkle CA; O'Brien SJ; Peng T
    Cell Physiol Biochem; 2017; 42(4):1342-1357. PubMed ID: 28700999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence.
    Li MR; Chen GH; Cai CJ; Wang GY; Zhao H
    Digestion; 2011; 84(2):134-41. PubMed ID: 21502763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression.
    Lau HK; Hsieh MJ; Yang SF; Wang HL; Kuo WH; Lee HL; Yeh CB
    Int J Med Sci; 2016; 13(7):556-61. PubMed ID: 27429592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
    Wang ZS; Guo WD; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
    PLoS One; 2015; 10(11):e0142727. PubMed ID: 26588210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
    Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
    BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value.
    Ren CX; Leng RX; Fan YG; Pan HF; Li BZ; Wu CH; Wu Q; Wang NN; Xiong QR; Geng XP; Ye DQ
    Oncol Rep; 2017 Aug; 38(2):886-898. PubMed ID: 28656201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma.
    Liu F; Luo L; Liu Z; Wu S; Zhang W; Li Q; Peng Y; Wei Y; Li B
    Mol Carcinog; 2020 Nov; 59(11):1243-1255. PubMed ID: 32869896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma.
    Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M
    Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma.
    Kim YR; Byun MR; Choi JW
    Cancer Biomark; 2018; 23(1):135-144. PubMed ID: 30010110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PIN1 in hepatocellular carcinoma is associated with TP53 gene status.
    Bae JS; Noh SJ; Kim KM; Jang KY; Park HS; Chung MJ; Park BH; Moon WS
    Oncol Rep; 2016 Oct; 36(4):2405-11. PubMed ID: 27499097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
    Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.